AUTOMATED PLACENTAL MEASUREMENT
A method for analyzing the placenta in two or three dimensions comprising: selecting one or more placental samples to be analyzed; obtaining a digital image of each placental sample; and performing an analysis on the digital images, wherein a mathematical algorithm is applied to the digital image. Three dimensional scanning is also used to measure the 3-D placental shape. The results of the analysis are correlated with data on health outcomes in infants, children, or adults and are used to assess future health risks to a patient.
1 . A method of analyzing the placenta comprising:
selecting a placental sample to be analyzed;
staining the sample;
obtaining a digital image of the stained placental sample; and
performing an analysis on the digital image, wherein said analysis comprises a mathematical algorithm, and wherein the analysis of the placenta is used to assess the timing, nature and magnitude of gestational stressors.
2 . The method of claim 1 wherein said stain is an immunohistochemical stain.
3 . The method of claim 1 , wherein the stain selected from the group consisting of hemotoxylin and eosin, hemosiderin and Masson trichrome.
4 . The method of claim 1 wherein said algorithm is selected from the group spatial fuzzy c-means algorithms, segmentation algorithms, boundary finding algorithms, counting algorithms, length measuring algorithms, branching algorithms, angle measuring algorithms, and color discriminating algorithms.
5 . A method of analyzing the placenta comprising:
selecting a placental sample to be analyzed;
staining the sample;
obtaining a digital image of the stained placental sample; and
performing an analysis on the digital image, wherein said analysis comprises a mathematical algorithm, and wherein the analysis of the placenta is used to assess future health risks to a patient.
6 . The method of claim 5 wherein said stain is an immunohistochemical stain.
7 . The method of claim 5 , wherein the stain selected from the group consisting of hemotoxylin and eosin, hemosiderin and Masson trichrome.
8 . The method of claim 5 wherein said algorithm is selected from the group spatial fuzzy c-means algorithms, segmentation algorithms, boundary finding algorithms, counting algorithms, length measuring algorithms, branching algorithms, angle measuring algorithms, and color discriminating algorithms.
9 . A method of analyzing the placenta comprising:
measuring the thickness of the placenta; and
determining a characteristic of the thickness of the placenta; wherein the characteristic is selected from the group consisting of a maximum thickness, a minimum thickness, a mean thickness, a variability in thickness, and a centroid thickness;
wherein the determined characteristic is used to assesthe timing, nature and magnitude of gestational stressors.
10 . A method of analyzing the placenta comprising:
measuring the thickness of the placenta; and
determining a characteristic of the thickness of the placenta; wherein the characteristic is selected from the group consisting of a maximum thickness, a minimum thickness, a mean thickness, a variability in thickness, and a centroid thickness;
wherein the determined characteristic is used to assesfuture health risks to a patient.
11 . A method of analyzing the placenta comprising:
performing a 3 dimensional scan of the placental sample to be analyzed;
extracting medically significant information from the 3 dimensional image; and
using the medically significant information to assess the timing, nature and magnitude of gestational stressors.
12 . The method of claim 11 wherein the medically significant information is selected from the group consisting of placental volume, thickness at any virtual cross-section, thickness at any radial distance from the umbilical cord or placental centroid, minimum and maximum thickness, placental perimeter, surface area, and segmented chorionic surface vascular structure.
13 . A method of claim 11 wherein: the surface vascular structure is extracted.
14 . The method of claim 13 wherein the vascular structure is further analyzed by a mathematical algorithm include segmentation, branching metrics, Fourier analysis, or other graph or network metrics that are used to assess the timing of an event or stress including infection to the developing placenta or fetus.
15 . A method of analyzing the placenta comprising:
performing a 3 dimensional scan of the placental sample to be analyzed;
extracting medically significant information from the 3 dimensional image; and
using the medically significant information to assess future health risks to a patient.
16 . The method of claim 15 wherein the medically significant information is selected from the group consisting of placental volume, thickness at any virtual cross-section, thickness at any radial distance from the umbilical cord or placental centroid, minimum and maximum thickness, placental perimeter, surface area, and segmented chorionic surface vascular structure.
17 . A method of claim 15 wherein: the surface vascular structure is extracted.
18 . The method of claim 17 wherein the vascular structure is further analyzed by a mathematical algorithm include segmentation, branching metrics, Fourier analysis, or other graph or network metrics that are used to assess the timing of an event or stress including infection to the developing placenta or fetus.